Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

今周大耳朵

沒人要的下市老藥,竟成台灣對抗「黴漿菌疫情」利器?深耕骨科的博晟,為何創業第一天就決定做抗生素|Morning早安學 EP701

13 Dec 2023

Description

「對於8歲以上的(黴漿菌)病人,博晟的『美諾幸(凍晶注射劑)』是一項選擇。」面對近來在國內蔓延的黴漿菌疫情,博晟生醫董事長陳德禮指出公司重要抗生素產品美諾幸,是台灣對抗黴漿菌的利器。 - 撰文|高小鳳 文章連結|https://reurl.cc/WveNWD - ★立即加入Podcast專屬交流社群 | discord.gg/ZCYX3MseRh -- Hosting provided by SoundOn

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.